abstract |
The invention is concerned with novel pyrrolidine derivatives of formula (I) n nwherein X, Y, R 1 , R 2 and R 3 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments. |